Regional Cancer Care Associates (RCCA) Researchers from John Theurer Cancer Center Present Leading-Edge Clinical Data in Blood Cancers at American Society of Hematology Meeting

Among 39 Abstracts Accepted -- PD-1 Immunotherapies in Blood Cancers and CAR-T Cell Therapy in B-cell Malignancies

Dec 04, 2015, 17:16 ET from John Theurer Cancer Center

ORLANDO, Fla., Dec. 4, 2015 /PRNewswire/ --


Andre Goy, M.D., M.S., Chairman, John Theurer Cancer Center and Chief, Division of Lymphoma, Hackensack University Medical Center;

Andrew L. Pecora, MD, FACP, CPE, Vice President of Cancer Services and Chief Innovation Officer, John Theurer Cancer Center


American Society of Hematology (ASH) 57th Annual Meeting & Exposition


December 5-8, 2015


Orange County Convention Center, Orlando, FL


John Theurer Cancer Center (JTCC) researchers, led by Drs. Goy and Pecora, are principal investigators/co-authors of 39 abstracts being presented at the ASH meeting representing the latest groundbreaking science in hematologic malignancies. This month, JTCC commemorates the 25th anniversary of its first bone marrow transplantation (BMT), a pioneering procedure performed by Dr. Pecora and his team; it is now one of the nation's top 10 BMT centers. Drs. Goy and Pecora are available to offer insights on key studies assessing PD-1 immunotherapies in blood cancers, and CAR-T cell therapy in the treatment of B-cell malignancies.

Follow our researchers with our Twitter handles @JTCancerCenter, @AndreGoyMD and Periscope @JTCancerCenter

To Access ASH Abstracts:

For more information, contact:
Ovidio Torres (on-site)
917-991-3399 (mobile)

Kristen Berry (on-site)
774-573-0455 (mobile)


SOURCE John Theurer Cancer Center